Literature DB >> 15383402

Derivation of a new formula for calculating urinary electrolyte-free water clearance based on the Edelman equation.

Minhtri K Nguyen1, Ira Kurtz.   

Abstract

In evaluating the renal mechanisms responsible for the generation of the dysnatremias, an analysis of free water clearance (FWC) and electrolyte-free water clearance (EFWC) is often utilized to characterize the rate of urinary free water excretion in these disorders. Previous analyses of FWC and EFWC have failed to consider the relationship among plasma water Na(+) concentration ([Na(+)](pw)), total exchangeable Na(+) (Na(e)), total exchangeable K(+) (K(e)), and total body water (TBW); (Edelman IS, Leibman J, O'Meara MP, and Birkenfeld LW. J Clin Invest 37: 1236-1256, 1958). In their derivations, the classic FWC and EFWC formulas fail to consider the quantitative and physiological significance of the slope and y-intercept in this equation. Consequently, previous EFWC formulas incorrectly assume that urine is isonatric when [Na(+) + K(+)](urine) = [Na(+)](p) or [Na(+) + K(+)](urine) = [Na(+)](p) + [K(+)](p) (where [Na(+)](p) and [K(+)](p) represent plasma Na(+) and K(+) concentrations, respectively). Moreover, previous formulas cannot be utilized in the setting of hyperglycemia. In this article, we have derived a new formula termed modified electrolyte-free water clearance (MEFWC) for determining the electrolyte-free water clearance, taking into consideration the empirical relationship between the [Na(+)](pw) and Na(e), K(e), and TBW: MEFWC = V [1 - 1.03[Na(+) + K(+)](urine)/([Na(+)](p) + 23.8)]. MEFWC, unlike previous formulas, is derived based on the requirement of the Edelman equation that urine is isonatric only when [Na(+) + K(+)](urine) = (Na(e) + K(e))/TBW = 0.97[Na(+)](p) + 23.1. Furthermore, since we have shown that the y-intercept in the Edelman equation varies directly with the plasma glucose concentration, in patients with hyperglycemia, MEFWC = V [1 - 1.03[Na(+) + K(+)](urine)/{[Na(+)](p) + 23.8 + (1.6/100)([glucose](p) - 120)}]. The MEFWC formula will be especially useful in assessing the renal contribution to the generation of the dysnatremias.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15383402     DOI: 10.1152/ajprenal.00259.2004

Source DB:  PubMed          Journal:  Am J Physiol Renal Physiol        ISSN: 1522-1466


  15 in total

Review 1.  Principles of quantitative water and electrolyte replacement of losses from osmotic diuresis.

Authors:  Maria-Eleni Roumelioti; Todd S Ing; Helbert Rondon-Berrios; Robert H Glew; Zeid J Khitan; Yijuan Sun; Deepak Malhotra; Dominic S Raj; Emmanuel I Agaba; Glen H Murata; Joseph I Shapiro; Antonios H Tzamaloukas
Journal:  Int Urol Nephrol       Date:  2018-03-06       Impact factor: 2.370

2.  Body sodium, potassium and water in peritoneal dialysis-associated hyponatremia.

Authors:  Yijuan Sun; David Mills; Todd S Ing; Joseph I Shapiro; Antonios H Tzamaloukas
Journal:  Perit Dial Int       Date:  2014-05       Impact factor: 1.756

3.  Short-term efficacy and safety of vasopressin receptor antagonists for treatment of hyponatremia.

Authors:  Bertrand L Jaber; Leena Almarzouqi; Lea Borgi; Victor F Seabra; Ethan M Balk; Nicolaos E Madias
Journal:  Am J Med       Date:  2011-10       Impact factor: 4.965

Review 4.  Improving on the Adrogué-Madias Formula.

Authors:  Sheldon Chen; Michael Shieh; Robert Chiaramonte; Jason Shey
Journal:  Kidney360       Date:  2020-12-04

5.  Severe hypernatremia from a urea-induced diuresis due to body protein wasting in an insulin-resistant type 2 diabetic patient.

Authors:  Amy Anderson; Eugene J Barrett
Journal:  J Clin Endocrinol Metab       Date:  2013-03-14       Impact factor: 5.958

6.  Whole-body electrolyte-free water clearance: derivation and clinical utility in analyzing the pathogenesis of the dysnatremias.

Authors:  Minhtri K Nguyen; Ira Kurtz
Journal:  Clin Exp Nephrol       Date:  2006-03       Impact factor: 2.801

7.  Electrolyte-free water clearance: a key to the diagnosis of hypernatremia in resolving acute renal failure.

Authors:  Gabor Bodonyi-Kovacs; Stewart H Lecker
Journal:  Clin Exp Nephrol       Date:  2008-01-09       Impact factor: 2.801

8.  The utility and accuracy of four equations in predicting sodium levels in dysnatremic patients.

Authors:  Ramy Magdy Hanna; Wan-Ting Yang; Eduardo A Lopez; Joseph Nabil Riad; James Wilson
Journal:  Clin Kidney J       Date:  2016-05-24

9.  Tolvaptan for hyponatremia with preserved sodium pool in critically ill patients.

Authors:  Michele Umbrello; Elena S Mantovani; Paolo Formenti; Claudia Casiraghi; Davide Ottolina; Martina Taverna; Angelo Pezzi; Giovanni Mistraletti; Gaetano Iapichino
Journal:  Ann Intensive Care       Date:  2016-01-04       Impact factor: 6.925

10.  Treatment of Cirrhosis-Associated Hyponatremia with Midodrine and Octreotide.

Authors:  Sharad Patel; Dai-Scott Nguyen; Anjay Rastogi; Minh-Kevin Nguyen; Minhtri K Nguyen
Journal:  Front Med (Lausanne)       Date:  2017-03-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.